Gan & Lee Pharmaceuticals
SSE:603087
Wall Street
Price Targets
Price Targets Summary
Gan & Lee Pharmaceuticals
According to Wall Street analysts, the average 1-year price target for
Gan & Lee Pharmaceuticals
is 70.35 CNY
with a low forecast of 55.5 CNY and a high forecast of 87.15 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Gan & Lee Pharmaceuticals's stock price target?
Price Target
70.35
CNY
According to Wall Street analysts, the average 1-year price target for
Gan & Lee Pharmaceuticals
is 70.35 CNY
with a low forecast of 55.5 CNY and a high forecast of 87.15 CNY.
What is Gan & Lee Pharmaceuticals's Revenue forecast?
Projected CAGR
28%
For the last 6 years the
compound annual growth rate for
Gan & Lee Pharmaceuticals's revenue is
4%.
The projected
CAGR
for the next 3 years is
28%.
What is Gan & Lee Pharmaceuticals's Operating Income forecast?
Projected CAGR
80%
For the last 6 years the
compound annual growth rate for
Gan & Lee Pharmaceuticals's operating income is
-19%.
The projected
CAGR
for the next 3 years is
80%.
What is Gan & Lee Pharmaceuticals's Net Income forecast?
Projected CAGR
44%
For the last 6 years the
compound annual growth rate for
Gan & Lee Pharmaceuticals's net income is
-7%.
The projected
CAGR
for the next 3 years is
44%.
